ProKidney
Price & Volume
Stats
See moreOpen | $1.78 |
Previous Close | $1.83 |
Day Range | $1.72-$1.83 |
52W Range | $0.46-$5.95 |
Market Cap | $551.2M |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $893,000 |
Revenue Growth (YoY) | 196.1% |
Gross Profit (12 Mos) | $893,000 |
Diluted EPS | -$0.53 |
News
See moreYahoo Finance • 8 days ago
ProKidney Expects Phase 3 PROACT 1 Pivotal Trial Results For Rilparencel In Q2 2027
Yahoo Finance • 23 days ago
Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
Yahoo Finance • last month
3 Promising Penny Stocks With At Least $600M Market Cap
Yahoo Finance • 4 months ago
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
About
CEO | Dr. Bruce Culleton M.D. |
Address | 2000 Frontis Plaza Boulevard, Winston-Salem, NC, United States, 27103 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 231 |
